PHILADELPHIA, Sept. 24 /PRNewswire/ -- Today Astellas Pharma US, Inc. ("Astellas") announced the Launch of the Appropriate Use Criteria (AUC) for Cardiac Radionuclide Imaging application (app) for smartphones. The app is designed to give physicians access to published criteria used to assess the nee
Source : http://www.prnewswire.com/news-releases/new-smartp...
Source : http://www.prnewswire.com/news-releases/new-smartp...